Screener
Ironwood Pharmaceuticals IRWD Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 8,443 | 9,340 |
| Intangible assets, net | 1,633 | 2,040 |
| Deferred tax assets | 69,064 | 103,433 |
| Other assets | 3,874 | 4,502 |
| Total assets | $285,128 | $396,901 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $911 | $2,898 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's other non-current assets?
- Ironwood Pharmaceuticals (IRWD) reported other non-current assets of $3.87M in Q2 2026.
- How has Ironwood Pharmaceuticals's other non-current assets changed year-over-year?
- Ironwood Pharmaceuticals's other non-current assets decreased by 24.8% year-over-year, from $5.15M to $3.87M.
- What is the long-term trend for Ironwood Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's other non-current assets has grown at a 36.7% compound annual growth rate (CAGR), from $943K to $4.5M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Ironwood Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude